Company Filing History:
6 out of 6 
1 out of 3 
1 out of 822 
Years Active: 2022-2025
Title: The Innovative Work of Steven Robinette: Pioneering RNA-Editing Oligonucleotides
Introduction:
Steven Robinette, based in Fremont, NH, is a trailblazing inventor making significant contributions in the field of RNA-editing oligonucleotides. With a total of two patents under his name, Robinette exemplifies dedication and expertise in cutting-edge therapeutic solutions.
Latest Patents:
Robinette's latest patents include groundbreaking inventions in the realm of RNA-editing oligonucleotides. His pioneering work focuses on developing compositions and methods to treat disorders through deamination of adenosine in mRNA, thereby offering therapeutic benefits to individuals in need.
Career Highlights:
Currently associated with Korro Bio, Inc., Robinette plays a pivotal role in shaping innovative solutions within the biotechnology landscape. His relentless pursuit of scientific excellence and problem-solving skills reflect in his patented inventions that hold immense promise for the medical field.
Collaborations:
In his professional journey, Robinette collaborates closely with accomplished peers such as Andrew W Fraley and Nessan Anthony Bermingham. Together, they form a dynamic team driving forward the boundaries of RNA-editing technology and its potential applications in healthcare.
Conclusion:
Steven Robinette's remarkable work stands as a testament to his visionary approach and commitment to advancing medical science through innovative technologies. With a focus on RNA-editing oligonucleotides, Robinette's patents pave the way for transformative treatments and hold the promise of improving lives worldwide.